drug

Dietary Supplement: Pregnenolone

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by VA Office of Research and Development
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia
NCT00728728Phase 2Completed

KOLs & investigators

1
Christine E Marx, MD, MAKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
VA Office of Research and Development
company
trial
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia
PHASE2
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Christine E Marx, MD, MA
KOL score 5
person